HUTCHMED (China) Investor Relations Material
Latest events
H2 2023
HUTCHMED (China)
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from HUTCHMED (China) Limited
Access all reports
HUTCHMED (China) Limited was founded to discover, develop, and commercialize targeted therapeutics and immunotherapies for cancer and immunological diseases. The company have developed a core platform technology which combines three unique developments from both the laboratory and their experience with pharmaceutical artificial intelligence: data-driven design of next-generation antibodies, prediction of off-target binding sites, and targeted delivery of therapeutic agents.
Key slides for HUTCHMED (China) Limited
H2 2023
HUTCHMED (China) Limited
Deutsch Bank Depositary Receipts Virtual Investor Conference
HUTCHMED (China) Limited
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇬🇧 United Kingdom